Assignee
ORIC PHARMACEUTICALS INC
US·20 granted patents·16 pending applications·57 citations·filing 2016–2025
Top patents by PatentIndex Score
36 records- 0196US11028120B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted Jun 8, 2021·10 cites·30 claims
- 0295US12018043B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Granted Jun 25, 2024·6 cites·33 claims
- 0395US11130778B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2021·Granted Sep 28, 2021·8 cites·30 claims
- 0494US11530236B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted Dec 20, 2022·4 cites·25 claims
- 0593US11325938B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted May 10, 2022·9 cites·20 claims
- 0691US11858915B2Polo like kinase 4 inhibitorsORIC PHARMACEUTICALS INC·Filed 2023·Granted Jan 2, 2024·3 cites·21 claims
- 0791US11129841B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2018·Granted Sep 28, 2021·7 cites·20 claims
- 0890US10472387B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2019·Granted Nov 12, 2019·2 cites·6 claims
- 0990US2026042794A1Cd73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1088US11377469B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2018·Granted Jul 5, 2022·5 cites·19 claims
- 1187US12454544B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2024·Granted Oct 28, 2025·0 cites·9 claims
- 1286US11576922B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2021·Granted Feb 14, 2023·1 cites·41 claims
- 1385US11807658B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Granted Nov 7, 2023·1 cites·19 claims
- 1483US2025368677A1Cd73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1579US11124537B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Sep 21, 2021·1 cites·23 claims
- 1676US10723759B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2019·Granted Jul 28, 2020·0 cites·28 claims
- 1776US2023096870A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1876US2024124512A1Cd73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1972US12577272B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted Mar 17, 2026·0 cites·45 claims
- 2070US12312339B2Polo like kinase 4 inhibitorsORIC PHARMACEUTICALS INC·Filed 2023·Granted May 27, 2025·0 cites·22 claims
- 2170US10836789B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2020·Granted Nov 17, 2020·0 cites·30 claims
- 2269US2021017219A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2367US2022259253A1Cd73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2465US2024270722A1Polo like kinase 4 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2564US2021379084A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2661US2021395295A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2759US11110103B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Sep 7, 2021·0 cites·12 claims
- 2858US2025034159A1Inhibitors of epidermal growth factor receptorORIC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2954US2024398811A1Prc2 inhibitors for use in treating blood disordersORIC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3052US12544391B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted Feb 10, 2026·0 cites·31 claims
- 3152US2026092068A1Physical forms of an inhibitor of prc2ORIC PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3252US2023302014A1Uses of glucocorticoid receptor (gr) antagonist and androgen receptor (ar) degrader combinationsORIC PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3347US2021147472A1Solid forms and formulations comprising a glucocorticoid receptor antagonist and uses thereofORIC PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3446US2021122730A1Glucocorticoid receptor modulatorsORIC PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3544US2022079924A1Glucocorticoid receptor modulatorsORIC PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3642US11208432B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Dec 28, 2021·0 cites·35 claims
Join the waitlist — get patent alerts
Get an alert when ORIC PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →